Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/MEDP
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Medpace Holdings Inc (MEDP) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

MEDP trades at $538.23, up 0.51% with a bullish technical signal and strong fundamentals. The stock shows robust profitability with 17.19% net margins and 77.25% ROE, though valuations appear elevated with a P/E of 33.87. Recent earnings consistently beat expectations, and 2026 projections indicate revenue growth to $2.7B. Technical analysis shows support at $527 and resistance at $543, with the current price near pivot point $535.
MEDP presents growth potential from strong CRO demand and earnings momentum, but faces risks from class action lawsuits and elevated valuation multiples. Analyst consensus is cautious with 74% hold ratings and a $479 price target below current levels. The stock's outlook depends on maintaining backlog quality amid rising cancellations and AI investment delays.
Read full analysis

Key Stats

  • Market Cap
    $15.37B
  • Volume
    -
  • Sector
    Technology
  • 52W High
    $620.59
  • 52W Low
    $308.88
  • Typical Hold Time
    -
  • Enterprise Value
    $14.84B
  • Div Yield
    -
  • Trading Activity
    -
$529.96
52W Low: $308.88
21 Jul 2025
52W High: $620.59
21 Jan 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $308.88 and a high of $620.59, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Most Recent News

Content is generated by Aura AI

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...

Market News
2 hours ago
Na
Bullish
news icon
pluang ai news

Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...

Market News
2 hours ago
Na
Bullish
news icon
pluang ai news

Alamar Biosciences launches national study using blood tests to advance Alzheimer's biomarker research.

Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...

Market News
2 hours ago
Na
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $15.37B
  • Volume
    -
  • Sector
    Technology
  • 52W High
    $620.59
  • 52W Low
    $308.88
  • Typical Hold Time
    -
  • Enterprise Value
    $14.84B
  • Div Yield
    -
  • Trading Activity
    -
$529.96
52W Low: $308.88
21 Jul 2025
52W High: $620.59
21 Jan 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $308.88 and a high of $620.59, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!